Processa Pharmaceuticals, Inc.
PCSA
$0.2294
$0.01145.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.79% | -3.87% | 19.38% | -12.44% | -10.41% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 50.00% | 100.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.57% | 41.24% | 0.74% | 1.32% | -7.99% |
| Change in Net Operating Assets | 1,081.22% | -148.28% | 176.90% | 22.63% | -204.36% |
| Cash from Operations | 16.83% | -21.45% | 37.61% | -7.68% | -63.30% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.33% | 0.00% | -7.14% | 0.00% | -55.56% |
| Issuance of Common Stock | 42.39% | 707.90% | -41.01% | -- | -100.00% |
| Repurchase of Common Stock | -542.86% | -366.67% | 91.89% | -85.00% | 89.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.26% | 710.01% | -40.88% | 27,341.18% | -100.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.82% | 200.33% | 36.56% | 19.99% | -179.47% |